Polyethylene Glycol 3350 Powder, For Solution
NDC Package 68788-8601-2

11-digit billing NDC: 68788860102 · Billing unit: GM · 238 GM per package

Package Information

Polyethylene Glycol 3350 powders is (Bottle Only) •  do not take more than directed unless advised by your doctor • the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap) • adults and children 17 years of age and older:    • use once a day    • fill to top of white section in cap which is marked to indicate the correct dose (17 g)    • stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink    • do not combine with starch-based thickeners used for difficult swallowing    • ensure that the powder is fully dissolved before drinking     • do not drink if there are any clumps    • do not use  more than 7 days • children 16 years of age or under: ask a doctor   (Packet Only) • do not take more than directed unless advised by your doctor • adults and children 17 years of age and older:   • use once a day   • stir and dissolve one packet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink   • do not combine with starch-based thickeners used for difficult swallowing   • ensure that the powder is fully dissolved before drinking    • do not drink if there are any clumps   • do not use more than 7 days • children 16 years of age or under: ask a doctor. This formulation utilizes a powder, for solution delivery system. Marketed by Preferred Pharmaceuticals Inc., this product is identified by NDC 68788-8601 and is authorized under FDA application ANDA214990.

Identification & Billing

NDC Package Code
68788-8601-2
Package Description
238 g in 1 BOTTLE
Product Code
11-Digit Billing Format
68788860102
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
238 GM
RxNorm Crosswalk
  • RxCUI: 876193 - polyethylene glycol 3350 17 GM Powder for Oral Solution
  • RxCUI: 876193 - polyethylene glycol 3350 17000 MG Powder for Oral Solution

Clinical Specifications

Proprietary Name
Polyethylene Glycol 3350
Non-Proprietary Name
Polyethylene Glycol 3350
Substance Name
Polyethylene Glycol 3350
Dosage Form
Powder, For Solution - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
(Bottle Only) •  do not take more than directed unless advised by your doctor • the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap) • adults and children 17 years of age and older:    • use once a day    • fill to top of white section in cap which is marked to indicate the correct dose (17 g)    • stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink    • do not combine with starch-based thickeners used for difficult swallowing    • ensure that the powder is fully dissolved before drinking     • do not drink if there are any clumps    • do not use  more than 7 days • children 16 years of age or under: ask a doctor   (Packet Only) • do not take more than directed unless advised by your doctor • adults and children 17 years of age and older:   • use once a day   • stir and dissolve one packet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink   • do not combine with starch-based thickeners used for difficult swallowing   • ensure that the powder is fully dissolved before drinking    • do not drink if there are any clumps   • do not use more than 7 days • children 16 years of age or under: ask a doctor

Regulatory & Marketing

Labeler Name
Preferred Pharmaceuticals Inc.
Product Type
Human Otc Drug
FDA Application #
ANDA214990
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-08-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68788-8601-2 identifies a specific commercial package of 238 g in 1 bottle of Polyethylene Glycol 3350, a human over the counter drug labeled by Preferred Pharmaceuticals Inc.. This product is billed per "GM" gram and contains an estimated amount of 238 billable units per package. This powder, for solution is formulated for oral use and contains polyethylene glycol 3350 as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Preferred Pharmaceuticals Inc. on March 08, 2024. The current certification is valid through December 31, 2027.

How is this Preferred Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68788860102. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 238 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68788-8601-2
11-Digit CMS (5-4-2)
68788-8601-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.